When Irked by Merck, Call a Fosamax Lawyer
When Irked by Merck, Call a Fosamax Lawyer
On the very day Fosamax was launched in the market, Merck has been raking millions of dollars. But the phenomenon was a big catastrophe as thousands of Fosamax lawsuits across the country are rising like mushrooms, demanding compensations and damages.
One high profile story is that of a Massachusetts woman, Elayne Danker, who filed a Fosamax fracture lawsuit against Merck a couple of months ago. She claims that the drug is the suspect of her broken thighbone. She was taking Fosamax beginning 2003 all through 2010 resulting in a low trauma femur fracture in March 2010.
Danker started taking Fosamax in September 2003 to prevent osteoporosis. She narrated that in the summer of 2009 she began experiencing unexplained thigh pain. She also began to observe problems performing routine activities such as speed walking and gardening. Her doctors were not able to diagnose the cause for the pain despite some comprehensive examinations. Then, in March 2010, she suffered a major injury after a fall that broke her thighbone. This prompted her to claim for damages via a lawsuit alleging that she suffered permanent disfiguration, scarring, and the disability to live an independent life.
Elayne Danker’s story is just one case in a considerable number of Fosamax related cases where patients are not being forewarned on the dangerous side effects of Fosamax. The sad incidences are also disappointing for many Merck product users who are now being alarmed and doubt the credibility of the research done by the manufacturer prior to releasing Fosamax into the market.
Danker’s condition representative of the sufferings currently undergone by so many of Fosamax users. The drug that promised to free sufferers of serious bone ailments turns out to be slowly annihilating their bones and their lives in the process.
Fosamax or alendronate, an osteoporosis drug, is part of a class of medications called bisphosphonates. It works by helping increase bone thickness (density) while decreasing the loss of bone tissue. Fosamax lawyers based their confidence on damage claims when the dangerous side effects of Fosamax were revealed to the public by the FDA in 2004. The revelation was followed by a new 2008 warning that links the drug to jaw osteonecrosis and femur fractures; a risk that’s three times higher than normal.